Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats.
Saved in:
| Title: | Sitagliptin attenuates cardiomyopathy by modulating the JAK/STAT signaling pathway in experimental diabetic rats. |
|---|---|
| Authors: | Al-Rasheed NM; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University., Al-Rasheed NM; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University; Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia., Hasan IH; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University., Al-Amin MA; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University., Al-Ajmi HN; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University., Mahmoud AM; Physiology Division, Department of Zoology, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt. |
| Source: | Drug design, development and therapy [Drug Des Devel Ther] 2016 Jun 28; Vol. 10, pp. 2095-107. Date of Electronic Publication: 2016 Jun 28 (Print Publication: 2016). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
